HSCS
Heart Test Laboratories Inc

3,090
Loading...
Loading...
News
all
press releases
Head to Head Review: Heart Test Laboratories (NASDAQ:HSCS) & ReWalk Robotics (NASDAQ:LFWD)
Heart Test Laboratories (NASDAQ:HSCS - Get Free Report) and ReWalk Robotics (NASDAQ:LFWD - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast...
Zolmax·1y ago
News Placeholder
More News
News Placeholder
HeartSciences to Present at the LD Micro Invitational XIV Conference
Southlake, TX, April 02, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...
Globe Newswire·1y ago
News Placeholder
Heart Test Laboratories, Inc. (NASDAQ:HSCS) Short Interest Update
Heart Test Laboratories, Inc. (NASDAQ:HSCS Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest...
Ticker Report·1y ago
News Placeholder
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
Data Demonstrated the Use of MyoVista wavECGTM for Screening Preoperative Patients for LVDD Can Be RecommendedSouthlake, Texas, March 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc...
Globe Newswire·1y ago
News Placeholder
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
Southlake, TX, March 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
Globe Newswire·2y ago
News Placeholder
Critical Survey: Heart Test Laboratories (NASDAQ:HSCS) and Ortho Regenerative Technologies (OTCMKTS:ORTIF)
Heart Test Laboratories (NASDAQ:HSCS Get Free Report) and Ortho Regenerative Technologies (OTCMKTS:ORTIF Get Free Report) are both small-cap medical companies, but which is the better...
Zolmax·2y ago
News Placeholder
HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
Data Demonstrated MyoVista AI-ECG model significantly outperformed NT-proBNP and ARIC HF score, the conventional standards of care for Stage B Heart Failure screeningSouthlake, Texas, March 12, 2024...
Globe Newswire·2y ago
News Placeholder
HeartSciences Announces Canada Patent Grant Covering MyoVista Wavelet Technology
Southlake, TX, March 06, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) ( HeartSciences or the Company ), an artificial intelligence (AI)-powered...
Globe Newswire·2y ago
News Placeholder
HeartSciences Adds Key Advisor to its Scientific Advisory Board
Southlake, TX, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
Globe Newswire·2y ago
News Placeholder
HeartSciences Expands its Scientific Advisory Board
Southlake, TX, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
Globe Newswire·2y ago

Latest HSCS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.